Table 1.
Characteristics of Participants and Facilities | N = 89 |
---|---|
Participant characteristics | |
Current gender identity (How do you describe yourself?), n (%)b | |
Male | 38 (43) |
Female | 47 (53) |
Age, n (%) | |
≤ 25 years | 0 (0) |
26–35 years | 23 (26) |
36–45 years | 26 (29) |
46–55 years | 16 (18) |
56 and older | 20 (22) |
Race ethnicity, n (%)b | |
Non-Hispanic Asian | 7 (8) |
Non-Hispanic Black or African-American | 5 (6) |
Non-Hispanic White | 63 (71) |
Other race/ethnicitya | 5 (6) |
Highest degree, n (%)b | |
Bachelor’s degree | 4 (4) |
Master’s degree | 6 (7) |
MD or DO | 31 (35) |
PharmD | 36 (40) |
Other doctoral degree | 10 (11) |
Years in primary role, n (%) | |
5 years or less | 38 (43) |
6–10 years | 18 (20) |
11–15 years | 16 (18) |
16 years or more | 14 (16) |
What is your primary role in the VA? n (%)b | 36 (40) |
Administrator | 12 (13) |
Clinician | 36 (40) |
Pharmacist | 37 (42) |
Other | 2 (2) |
How many hours per week do you see patients? n (%)b | |
≤ 10 h | 31 (35) |
11–20 h | 14 (16) |
21–30 h | 21 (24) |
31–40 h | 19 (21) |
Opioid prescribing privileges, n (%)b | 37 (42) |
Facility characteristics | |
Number of visits, median (IQR) | 561098 (195920,926276) |
Facility complexity, n (%) | |
1a, 1b, or 1c | 66 (74) |
2 | 8 (9) |
3 | 15 (17) |
Rural, n (%) | 12 (14) |
Case reviews requested, median (IQR) | 18 (19) |
PC panel patient size (per 100 patients), median (IQR) | 918 (121) |
Academic detailing through pain campaign, median (IQR) | 21 (48) |
Academic detailing around STORM dashboard, n (%) | 48 (54) |
All employee survey, workplace performance, median (IQR) | 4 (0) |
aOther includes those who indicated Hispanic ethnicity or more than one racial/ethnic group
bPercentages may not sum to 100% due to non-response/missing data; Proportion of participants who selected the option “prefer not to answer” for the following demographic questions: “current gender identity (4.5%),” “race ethnicity (10.1%),” “highest degree (2.3%),” “primary role in VA (2.3%),” “hours seeing patients (4.5%),” and “opioid prescribing privileges (2.3%)”